BioComputing

BioComputing

Investigación biotecnológica

LEIOA, Bizkaia 99 seguidores

Sobre nosotros

We are a multidisciplinary group made up of: physicists, chemists, biochemists and mathematicians who have recently come together to address biophysics problems. Our mission is to offer complementary computational support to any laboratory or industry in the BIO world that wishes to integrate in-silico techniques into experiments.

Sitio web
https://biocomputing.es/
Sector
Investigación biotecnológica
Tamaño de la empresa
De 2 a 10 empleados
Sede
LEIOA, Bizkaia
Tipo
De financiación privada
Fundación
2024
Especialidades
Biophysics, Bioinformatics, machine learning y deep leraning

Ubicaciones

  • Principal

    Barrios Sarriena s/n

    LEIOA, Bizkaia 48940, ES

    Cómo llegar

Empleados en BioComputing

Actualizaciones

  • Ver la página de empresa de BioComputing, gráfico

    99 seguidores

    Please review our most recent research, which has been submitted for publication. This research introduces an online tool designed to predict the pathogenicity of mutations in the KCNQ2 channel.

    Ver la página de empresa de BioComputing, gráfico

    99 seguidores

    BCB is delighted to announce our latest project – an online tool grounded in machine learning designed to predict the pathogenicity of mutations in ion channels. In the link provided below, we introduce a versatile methodology capable of precisely classifying missense variants in KCNQ2, offering valuable insights for clinical counseling and aiding in determining the severity of the variant. The MLe-KCNQ2 ensemble model, accessible at https://channels.bcb.eus/, effectively categorizes pathogenic mutations as either benign or severe, boasting specificity and sensitivity values surpassing 0.95. We have plans to unveil many more ion channels in the near future, so stay tuned for updates. Explore the tool here: https://channels.bcb.eus/

    • No hay descripción de texto alternativo para esta imagen
  • Ver la página de empresa de BioComputing, gráfico

    99 seguidores

    BCB is delighted to announce our latest project – an online tool grounded in machine learning designed to predict the pathogenicity of mutations in ion channels. In the link provided below, we introduce a versatile methodology capable of precisely classifying missense variants in KCNQ2, offering valuable insights for clinical counseling and aiding in determining the severity of the variant. The MLe-KCNQ2 ensemble model, accessible at https://channels.bcb.eus/, effectively categorizes pathogenic mutations as either benign or severe, boasting specificity and sensitivity values surpassing 0.95. We have plans to unveil many more ion channels in the near future, so stay tuned for updates. Explore the tool here: https://channels.bcb.eus/

    • No hay descripción de texto alternativo para esta imagen

Páginas similares